Recipharm signs MOU for fill finish factory for vaccines and biotherapeutics in Morocco
Recipharm has signed a Memorandum of Understanding (MOU) with Morocco to operate a new fill finish factory in the country.
Recipharm has signed a Memorandum of Understanding (MOU) with Morocco to operate a new fill finish factory in the country.
Novasep has signed a manufacturing services agreement with Exelixis, an oncology-focused US biotechnology company, for the cGMP clinical production of XB002, a next-generation tissue factor-targeting antibody-drug conjugate (ADC).
Cell therapy player, Bone Therapeutics, has secured up to €16m (US$18.9m) in a financing loan from the European Investment Bank (EIB) to accelerate ongoing clinical and commercial development of innovative orthopedic treatments.
Eli Lilly and Company will make an equity investment of around $15m in MiNA Therapeutics: a company with a proprietary small activating RNA (saRNA) technology platform.